ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Antioxidant Supplementation in Trauma Patients

This study is currently recruiting participants.
Verified by Boston Medical Center, January 2008

Sponsored by: Boston Medical Center
Information provided by: Boston Medical Center
ClinicalTrials.gov Identifier: NCT00613392
  Purpose

Administration of antioxidants to trauma patients will improve measures of oxidant stress in the blood


Condition Intervention Phase
Multiple Trauma
Dietary Supplement: powdered antioxidant
Dietary Supplement: powdered cornstarch placebo
Phase III

MedlinePlus related topics:   Antioxidants    Dietary Supplements    Injuries    Stress    Wounds   

Drug Information available for:   Starch   

U.S. FDA Resources

Study Type:   Interventional
Study Design:   Prevention, Randomized, Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Parallel Assignment, Safety/Efficacy Study
Official Title:   Antioxidant Supplementation in Trauma Patients

Further study details as provided by Boston Medical Center:

Primary Outcome Measures:
  • measures of malondialdehyde level/total antioxidant status and F2 isoprostane [ Time Frame: 7 days ] [ Designated as safety issue: No ]

Estimated Enrollment:   40
Study Start Date:   November 2007
Estimated Primary Completion Date:   November 2009 (Final data collection date for primary outcome measure)

Arms Assigned Interventions
1: Experimental Dietary Supplement: powdered antioxidant
one vial mixed with water every day orally or through enteral tube
2: Placebo Comparator Dietary Supplement: powdered cornstarch placebo
one vial mix with water and administer orally or via enteral tube

  Eligibility
Ages Eligible for Study:   18 Years to 85 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Criteria

Inclusion Criteria:

  • Adult non pregnant non lactating trauma patient

Exclusion Criteria:

  • GCS <6
  • Renal dysfunction (cre > 2.5 mg/dl)
  • Hepatic dysfunction ( TBili > 3.0 mg/dl)
  • Expected survival < 48 hours
  • Burns over > 20% body surface area
  • Immune-deficiency syndromes
  • Steroid use
  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00613392

Contacts
Contact: Lorraine S Young, RD,MS     617-638-8597     lorrie.young@bmc.org    

Locations
United States, Massachusetts
Boston Medical Center     Recruiting
      Boston, Massachusetts, United States, 02118
      Contact: Lorraine S Young, RD,MS     617-638-8597     Lorrie.young@bmc.org    

Sponsors and Collaborators
Boston Medical Center

Investigators
Study Director:     Peter Burke, MD     Boston Medical Center    
  More Information


Responsible Party:   Boston Medical Center ( Suresh Agarwal MD )
Study ID Numbers:   H-25038
First Received:   January 30, 2008
Last Updated:   February 11, 2008
ClinicalTrials.gov Identifier:   NCT00613392
Health Authority:   United States: Institutional Review Board

Keywords provided by Boston Medical Center:
antioxidant  
oxidant stress  
trauma  
free radical  

Study placed in the following topic categories:
Multiple Trauma
Wounds and Injuries
Disorders of Environmental Origin
Stress

ClinicalTrials.gov processed this record on October 23, 2008




Links to all studies - primarily for crawlers